Document is current
Any future updates will be listed below
-
Authors
Zhang, Chi https://orcid.org/0000-0003-2693-6643
Lim, Haeyn
Ballheim, Jennifer D. https://orcid.org/0009-0003-5249-7354
Simón, Marina
Fu, Rui https://orcid.org/0000-0001-8183-4549
Tolman, Nicholas G.
Horbal, Logan J.
Juarez, Felicia A.
Wang, Qing
Bhandari, Aakriti
Montgomery, Christa https://orcid.org/0009-0004-2430-2772
Zhu, Ling
Crowston, Jonathan G.
Robine, Nicolas https://orcid.org/0000-0001-5698-8183
Fautsch, Michael P.
Elliott, Michael H. https://orcid.org/0000-0002-2289-8718
John, Simon W. M. https://orcid.org/0000-0002-4319-0356
-
Funding
Funding for this research was provided by:
Research to Prevent Blindness
U.S. Department of Health & Human Services | NIH | National Eye Institute (EY011721)
U.S. Department of Health & Human Services | NIH | National Eye Institute (R01EY032507)
U.S. Department of Health & Human Services | NIH | National Eye Institute (EY032062)
U.S. Department of Health & Human Services | NIH | National Eye Institute (R01EY018606)
U.S. Department of Health & Human Services | NIH | National Eye Institute (EY028608)
New York Fund for Innovation in Research and Scientific Talent
- License Information
-
More Information
Article History
Received: 23 June 2025
Accepted: 11 March 2026
First Online: 8 April 2026
Competing interests
: Columbia University has filed a provisional patent application covering diagnostic and therapeutic approaches targeting blood retinal barrier disruption to predict or prevent glaucoma, as described in this article (US Patent Application No. 19/447,563, pending). The inventors listed on the patent application include C.Z. and S.W.M.J. The remaining authors declare no competing interests.
